A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice

article OA: bronze CC0 ⤵ 61 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-07

This study investigated the antiangiogenic effects of a selective cyclooxygenase-2 inhibitor on endometriosis xenografts, observing suppression of tumor growth in SCID mice.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Angiogenesis Inhibitors Cyclooxygenase 2 Inhibitors Endometriosis Endometriosis Mice, SCID Neovascularization, Pathologic Nitrobenzenes Sulfonamides Adult Angiogenesis Inhibitors Animals Apoptosis Blood Vessels Blood Vessels Cell Proliferation Cell Proliferation Cyclooxygenase 2 Inhibitors Endometriosis Endometriosis Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
License: CC0 · commercial use OK